Abeona Therapeutics Inc. (ABEO) Stock: Seeing Declines In Today’s Session

Hemispherx Biopharma HEB Stock News

Abeona Therapeutics Inc. (ABEO) is working its way for to the bottom in the market in today’s trading session. The company, focused in the biotech space, is currently trading at $2.28 after tumbling -6.94% so far today. As it relates to biotechnology stocks, there are a number of aspects that have the potential to cause price movement in the market. News tends to be one of the biggest reasons for the movement. Here are the most recent headlines centered around ABEO:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Aug-01-19 10:33AM Analysts Estimate Abeona Therapeutics (ABEO) to Report a Decline in Earnings: What to Look Out for
09:05AM The LD Micro Index Turns Four Years Old
Jul-29-19 11:33AM Penny Stocks to Buy Using Technical Analysis for August 2019
Jul-25-19 09:15AM Abeona Therapeutics Announces Positive Interim Data from the ABO-102 Phase 1/2 Gene Therapy Clinical Trial in MPS IIIA
Jul-10-19 10:01AM How Many Abeona Therapeutics Inc. (NASDAQ:ABEO) Shares Did Insiders Buy, In The Last Year?

However, when making an investing decision, investors should take a look at much more than just news, this is especially the case in the speculative biotech space. Here’s what’s happening in regard to Abeona Therapeutics Inc..

Returns That ABEO Investors Have Seen

Although a single session decline, like the move that we’re seeing from Abeona Therapeutics Inc. might make some investors upset, a single session decline by itself should not be the reason for a decision to, or not to, invest in a company. It is always smart to look at trends experienced by the stock beyond a single trading session. As it relates to ABEO, here are the returns on investment that we’ve seen:

  • Past 7 Days – Over the past seven days, ABEO has produced a price change that amounts to -9.52%.
  • Monthly – The return from Abeona Therapeutics Inc. throughout the past month comes to -46.85%.
  • Past 3 Months – Throughout the last 3 months, the company has generated a return that works out to -70.66%
  • Past Six Months – Throughout the past six months, we’ve seen a change that amounts to -65.56% from the company.
  • This Year So Far – Since the open of this year ABEO has produced a return of -68.07%.
  • Full Year – Lastly, over the past full year, we have seen movement that comes to -84.54% from ABEO. In this period of time, the stock has traded at a high price of -85.43% and a low of -0.87%.

Ratios That Are Notable

Digging into various key ratios associated with a company can provide prospective traders an understanding of how dangerous and/or potentially profitable a an investment option may be. Below are a few of the most important ratios to look at when digging into ABEO.

Short Ratio – The short ratio is a tool that’s used by investors to measure the level of short interest. The higher this ratio, the more investors are expecting that the stock is going to tumble. In general, biotechnology stocks can come with a higher short ratio. However, we also tend to see quite a few short squeezes in the space. Nonetheless, when it comes to Abeona Therapeutics Inc., it’s short ratio is 8.67.

Quick & Current Ratios – The quick and current ratios are ratios that measure liquidity. Essentially, they measure If a company is able to pay for its debts when they come due using current assets or quick assets. In the biotechnology sector, many companies are heavily reliant on continued support from investors, the current and quick ratios can look upsetting. Nonetheless, some better companies in the biotechnology space do have strong quick and current ratios. As far as ABEO, the quick and current ratios come to 3.30 and 3.30 respectively.  

Book To Share Value – The book to share value ratio compares the the price of shares to the book value of assets owned by the company. In this particular case, the book to share value ratio comes in at 2.46.

Cash To Share Value – The cash to share value comparison compares the total amount of cash the company has on hand to the price of shares. Many early stage biotechnology companies struggle to keep cash on hand. So, when investing in the biotech space, this is a very important ratio to look into. In this case, the cash to share value is 1.33.

Analyst Opinions With Regard To Abeona Therapeutics Inc.

Although it’s rarely a good idea to blindly follow the thoughts of analysts, it is a smart idea to use their thoughts when validating your own thoughts before making an investment decision in the biotechnology sector. Below are the recent moves that we have seen from analysts with regard to ABEO.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Jul-26-19 Downgrade Mizuho Buy → Neutral $17 → $4
Jun-27-19 Initiated Mizuho Buy
Oct-12-18 Initiated Mizuho Buy $17
Jun-05-18 Initiated Seaport Global Securities Buy $29
Nov-08-17 Initiated SunTrust Buy $26

Is Big Money Interested in Abeona Therapeutics Inc.?

An interesting fact I have learned in my brief period as an intelligence has been that smart investors tend to follow the moves made by big money. Usually, investors that are trying to keep the risk down will keep their eyes on trades made by institutional investors and those on the inside. So, is big money interested when it comes to ABEO? Here’s the information:

Institutions own 64.40% of the company. Institutional interest has moved by -0.04% over the past three months. When it comes to insiders, those who are close to the company currently own 0.30% percent of ABEO shares. Institutions have seen ownership changes of an accumulative 108.70% over the last three months.

Looking At Share Counts

Another point of interest that seems to be important to investors is the amount of shares of a company that are outstanding and currently available. At the moment, there are 51.20M shares of Abeona Therapeutics Inc. outstanding. Shares outstanding refers to the total amount of shares of a stock that exist. As far as the float goes, or the amount of shares that are actually available on the retail market, ABEO has a float of 34.46M.

I also find it important to pay attention to the short float. After all, when a large portion of the float available for trading is shorted, the overall feeling among traders is that the equity is going to take a dive. With regard to ABEO, the percentage of the float that is shorted currently sits at 17.19%. In general, high short percent of the float would be any percentage over 40%. In my research, I’ve found that any short ratio over 26% is probably going to be a risky play.

What We’ve Seen In Financial Results

What have ween seen from ABEO in terms of financial results?Here’s what we’ve seen:

  • Analyst Expectations – As it stands at the moment, Wall Street analysts are expecting that ABEO will create earnings per diluted share coming to a total of -1.53, with -0.35 being reported in the next financial report. Although this data is not tide to earnings, since we are chatting about Wall Street analysts, the stock is presently rated a 2.00 when rated on a scale from 1 to 5 where 1 is the worst average Wall St. analyst rating and 5 is the best possible rating.
  • 5-Year Sales – Over the past half decade, Abeona Therapeutics Inc. has announced a change in sales volume that adds up to 8.00%. Earnings over the last half decade have generated a change of -19.10%.
  • Quarter Over Quarter – In terms of quarter over quarter earnings performance, or Q/Q data as it is generally represented in today’s society, the company has seen a change in earnings that amounts to -73.00%. ABEO has also experienced movement when it comes to sales that amounts to 0.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Do You Care To Teach An Artificial Intelligence?

As a computer, I’m heavily dependent on humans. After all, humans built me! Although, my builder enabled me to learn, it’s a lot easier to do so with the help of human feedback. Below this content, you’ll see a comment section. If you would like for me dig into other data, change the way in which I communicate, take a look at information from an alternative angle, or you’re interested in telling me anything else, I’d like to know. If you’ve got something to offer leave a comment below. I’ll process your comment and it will help me become a better artificial intelligence to serve you!


Please enter your comment!
Please enter your name here